sciencebriefs
13:00in productionCh. 1 · A tree-shaped cell with one job/ 13:00 · ceiling 15 min
Life sciences · Medicine

Dendritic cell

Ralph Steinman named dendritic cells in 1973 and spent decades arguing they were the bridge between innate and adaptive immunity, a case the field only fully accepted after his death, and this brief follows that argument and the cell's actual job.

Dendritic cells are antigen-presenting cells that sample the body's surroundings, break down captured pathogens, and display the resulting fragments to T cells, making them, on the account given here, the only cell type able to activate naive T cells outside lymphoid tissue. Ralph Steinman and Zanvil Cohn identified and named them in 1973 while working at Rockefeller University, a discovery that took years to be accepted before Steinman's role in defining their central place in adaptive immunity was recognised with a 2011 Nobel Prize, awarded days after his death in circumstances the Nobel committee had never faced before. The brief follows how dendritic cells decide between activating an immune response and enforcing tolerance, their exploitation by viruses such as HIV, and their growing use in cancer immunotherapy.

Life sciencesMedicineDiseaseGeneticsDisease across the network →
Chapters & takeaways6
  1. 0:08
    A tree-shaped cell with one job

    Dendritic cells are named for their branching projections and function as antigen-presenting cells, capturing pathogen fragments and displaying them to T cells.

  2. 2:10
    The only cell that can start from zero

    Dendritic cells are described as the only antigen-presenting cells able to activate naive T cells outside lymphoid tissue, giving them a uniquely central role in beginning an adaptive immune response.

  3. 4:20
    Named in 1973, doubted for years

    Ralph Steinman and Zanvil Cohn identified and named dendritic cells in 1973, but it took considerable time for the field to accept the cell's central role in adaptive immunity.

  4. 6:30
    A Nobel Prize awarded after death

    Steinman died three days before the Nobel committee announced his 2011 prize, and the committee let the award stand since it had been decided in good faith while he was still alive.

  5. 8:40
    Deciding whether to attack or stand down

    Dendritic cells do not just trigger immune responses, they also help enforce tolerance toward the body's own tissue, a second and equally necessary function.

  6. 10:50
    Exploited by viruses, recruited against cancer

    HIV uses a receptor on dendritic cells to hitch a ride toward T cells, while cancer immunotherapy increasingly tries to recruit the same cells to trigger an anti-tumour response instead.

Worth your time?

Yes. Study the whole thing.

4/ 5
What works
  • is specific about what makes dendritic cells uniquely able to activate naive T cells
  • tells the Steinman discovery and Nobel Prize story with real dates and named people
  • distinguishes the field's two dendritic cell subsets by what each actually does
  • does not overstate self-experimentation claims the source material does not support
What does not
  • give a full account of every dendritic cell subset across species
  • explain in depth how tolerance-inducing receptors decide against activation
  • cover dendritic cell-based cancer vaccines as a finished, proven therapy
Study it if
  • anyone who wants to know what an antigen-presenting cell actually does
  • readers interested in the Steinman Nobel Prize story specifically
  • people curious how cancer immunotherapy connects to basic dendritic cell biology
Skip it if
  • readers wanting a simple immune-system primer without the cell biology
  • anyone looking for a full account of dendritic cell disorders
The written brief4 min read

A tree-shaped cell with one job

Dendritic cells take their name from the branching, tree-like projections they develop, and the material treats that shape as inseparable from their function: those projections increase the surface area available for sampling the surrounding tissue for pathogens. Their core job is antigen presentation. An immature dendritic cell captures material from viruses or bacteria, breaks it into fragments, and, once activated, displays those fragments on its surface using MHC molecules so that T cells can recognise them. This puts dendritic cells at the meeting point between the immune system’s fast, non-specific innate defences and its slower, highly targeted adaptive response, since they are the ones translating a raw pathogen encounter into a signal T cells can actually act on. The material frames this translating role as the reason dendritic cells matter more than their relative rarity in the body would suggest.

The only cell that can start from zero

What sets dendritic cells apart from other antigen-presenting cells, according to the material, is that they are the only ones capable of activating a naive T cell, one that has never encountered its target antigen before, outside of lymphoid tissue. Other antigen-presenting cells can reinforce or redirect an immune response already underway, but starting one from a T cell that has not yet been primed appears to require a dendritic cell specifically. After capturing an antigen, a dendritic cell matures, upregulates costimulatory molecules alongside its antigen display, and migrates through the bloodstream or lymphatic system to reach the spleen or lymph nodes, where naive T cells are concentrated. This migration and maturation sequence is presented as the mechanical explanation for why dendritic cells sit at the actual starting point of an adaptive immune response rather than somewhere further along it.

Named in 1973, doubted for years

The cell type was identified and named in 1973 by Ralph Steinman, working as a postdoctoral fellow in Zanvil Cohn’s laboratory at Rockefeller University, who distinguished these cells from macrophages on the basis of specific molecular differences, including a distinct pattern of surface markers. Steinman went on to argue that dendritic cells functioned as the immune system’s own adjuvant, actively priming T cell responses rather than simply presenting antigen passively. The material indicates this argument took considerable time to gain acceptance within the field, consistent with how novel a claim it was that a single, relatively obscure cell type held this central a role. Recognition eventually came through the Albert Lasker Award in 2007 and, later, the Nobel Prize in Physiology or Medicine.

A Nobel Prize awarded after death

The Nobel Prize itself was announced under circumstances the awarding committee had never encountered before. Steinman died on 30 September 2011 from pancreatic cancer, and the Nobel committee announced his prize three days later, apparently unaware at the time of announcement that he had already died. Nobel statutes generally prohibit posthumous awards, but the committee determined that because the decision had been made in good faith while believing Steinman to be alive, the prize would stand as awarded, shared with Bruce Beutler and Jules Hoffmann. This is presented in the material as a genuinely unprecedented situation for the prize committee to navigate, and it gives the discovery story a specific, well-documented human dimension beyond the underlying cell biology.

Deciding whether to attack or stand down

Dendritic cells are not described purely as activators of immune responses; the material is equally clear that they help decide when not to respond. Certain receptors on the dendritic cell surface can push the cell toward inducing tolerance rather than activating T cells, a mechanism aimed at preventing the immune system from attacking the body’s own tissue. This dual capacity, to either trigger an attack or actively discourage one, is treated as central to keeping the two subtypes of conventional dendritic cells and the interferon-heavy plasmacytoid subtype distinct in what they contribute: some are geared toward activating cytotoxic T cells, others toward helper T cells, and the plasmacytoid subtype toward a strong antiviral interferon response rather than direct T cell priming.

Exploited by viruses, recruited against cancer

This is a strong hour for readers who want the actual cell biology behind terms like antigen-presenting cell, paired with a discovery story that has real narrative weight on its own. The material gives dendritic cells a specific, non-redundant role, activating naive T cells, that makes their importance concrete rather than assumed, and it does not inflate Steinman’s biography with details the source does not support. The closing material on HIV hijacking a dendritic cell receptor to reach T cells, and on cancer immunotherapy trying to recruit the same cells deliberately, gives the science a clear stake beyond the laboratory. It is a cell type worth knowing by name, and this brief gives the reasons why without resorting to hype.

Same field · Life sciences4 of 78
9:14
Abraham Maslow
10:30
Alan Turing
8:44
Alexander Fleming
13:00
Management of HIV/AIDS
Up next in Science

Dendrochronology

· 13:00

A single wooden beam found in Arizona in 1929 closed a gap between two separate tree-ring records and gave archaeologists a continuous calendar reaching back to the year 700, which this brief follows from an astronomer's sunspot obsession to modern art forgery detection.

Play nextBack to Life sciences
13:00